company background image
ADVENZYMES logo

Advanced Enzyme Technologies NSEI:ADVENZYMES Voorraadrapport

Laatste prijs

₹477.45

Marktkapitalisatie

₹53.5b

7D

7.2%

1Y

49.8%

Bijgewerkt

04 Nov, 2024

Gegevens

Financiële gegevens bedrijf +

Advanced Enzyme Technologies Limited

NSEI:ADVENZYMES Voorraadrapport

Marktkapitalisatie: ₹53.5b

ADVENZYMES Overzicht aandelen

Advanced Enzyme Technologies Limited houdt zich samen met haar dochterondernemingen bezig met onderzoek, ontwikkeling, productie en marketing van enzymen en probiotica in India, Europa, de Verenigde Staten, Azië en internationaal.

ADVENZYMES fundamentele analyse
Sneeuwvlok Score
Waardering1/6
Toekomstige groei4/6
Prestaties in het verleden4/6
Financiële gezondheid6/6
Dividenden3/6

Advanced Enzyme Technologies Limited Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Advanced Enzyme Technologies
Historische aandelenkoersen
Huidige aandelenkoers₹477.45
52 Week Hoogtepunt₹571.00
52 Week Laag₹308.00
Bèta0.42
11 maand verandering-2.96%
3 maanden verandering15.19%
1 Jaar Verandering49.84%
33 jaar verandering33.29%
5 jaar verandering168.16%
Verandering sinds IPO73.60%

Recent nieuws en updates

After Leaping 26% Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Are Not Flying Under The Radar

Aug 20
After Leaping 26% Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Are Not Flying Under The Radar

Recent updates

After Leaping 26% Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Are Not Flying Under The Radar

Aug 20
After Leaping 26% Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Are Not Flying Under The Radar

We Think Shareholders Are Less Likely To Approve A Pay Rise For Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) CEO For Now

Jul 19
We Think Shareholders Are Less Likely To Approve A Pay Rise For Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) CEO For Now

Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00

Jul 13
Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00

Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business

Apr 08
Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business

Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends

Sep 23
Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends

Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital

Feb 03
Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital

Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends

Aug 11
Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends

With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting

May 13
With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting

Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Paint A Concerning Picture

Mar 28
Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Paint A Concerning Picture

The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 185%, So Why Not Pay It Some Attention?

Mar 13
The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 185%, So Why Not Pay It Some Attention?

Don't Ignore The Fact That This Insider Just Sold Some Shares In Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)

Feb 21
Don't Ignore The Fact That This Insider Just Sold Some Shares In Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)

Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Feb 18
Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

I Built A List Of Growing Companies And Advanced Enzyme Technologies (NSE:ADVENZYMES) Made The Cut

Feb 03
I Built A List Of Growing Companies And Advanced Enzyme Technologies (NSE:ADVENZYMES) Made The Cut

What Kind Of Investors Own Most Of Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)?

Jan 19
What Kind Of Investors Own Most Of Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)?

What Do The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Tell Us?

Dec 28
What Do The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Tell Us?

The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 114%, So Why Not Pay It Some Attention?

Dec 13
The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 114%, So Why Not Pay It Some Attention?

Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?

Nov 28
Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Advanced Enzyme Technologies Limited's NSE:ADVENZYMES) Stock?

Nov 20
Are Strong Financial Prospects The Force That Is Driving The Momentum In Advanced Enzyme Technologies Limited's NSE:ADVENZYMES) Stock?

Here's Why I Think Advanced Enzyme Technologies (NSE:ADVENZYMES) Might Deserve Your Attention Today

Nov 05
Here's Why I Think Advanced Enzyme Technologies (NSE:ADVENZYMES) Might Deserve Your Attention Today

What You Need To Know About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Investor Composition

Oct 21
What You Need To Know About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Investor Composition

Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?

Oct 06
Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?

Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Stocks Shoot Up 31% But Its P/E Still Looks Reasonable

Sep 26
Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Stocks Shoot Up 31% But Its P/E Still Looks Reasonable

Rendement voor aandeelhouders

ADVENZYMESIN ChemicalsIN Markt
7D7.2%3.2%1.8%
1Y49.8%22.8%36.8%

Rendement versus industrie: ADVENZYMES exceeded the Indian Chemicals industry which returned 22.8% over the past year.

Rendement versus markt: ADVENZYMES exceeded the Indian Market which returned 36.8% over the past year.

Prijsvolatiliteit

Is ADVENZYMES's price volatile compared to industry and market?
ADVENZYMES volatility
ADVENZYMES Average Weekly Movement6.7%
Chemicals Industry Average Movement5.9%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.4%
10% least volatile stocks in IN Market4.0%

Stabiele aandelenkoers: ADVENZYMES has not had significant price volatility in the past 3 months compared to the Indian market.

Volatiliteit in de loop van de tijd: ADVENZYMES's weekly volatility (7%) has been stable over the past year.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
1957323Mukund Kabrawww.advancedenzymes.com

Advanced Enzyme Technologies Limited houdt zich samen met haar dochterondernemingen bezig met onderzoek, ontwikkeling, productie en marketing van enzymen en probiotica in India, Europa, de Verenigde Staten, Azië en internationaal. Het bedrijf biedt voedingssupplementen op basis van enzymen en probiotica voor menselijke gezondheidszorg en diervoeding, groente- en fruitverwerking, bakken, brouwen en mouten, zetmeel- en graanverwerking, eiwitmodificatie, gistverwerking, zuivel- en kaasverwerking en olie- en vetverwerking, evenals voor speciale toepassingen, biobrandstoffen en biokatalyse. Het bedrijf levert non-food enzymen voor textiel-, leer-, pulp- en papierverwerking, evenals reinigings- en schoonmaakmiddelen.

Advanced Enzyme Technologies Limited Samenvatting

Hoe verhouden de winst en inkomsten van Advanced Enzyme Technologies zich tot de beurswaarde?
ADVENZYMES fundamentele statistieken
Marktkapitalisatie₹53.51b
Inkomsten(TTM)₹1.39b
Inkomsten(TTM)₹6.31b

38.5x

Koers/Winstverhouding

8.5x

P/S-verhouding

Is ADVENZYMES overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
ADVENZYMES resultatenrekening (TTM)
Inkomsten₹6.31b
Kosten van inkomsten₹1.55b
Brutowinst₹4.76b
Overige uitgaven₹3.38b
Inkomsten₹1.39b

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

Nov 09, 2024

Winst per aandeel (EPS)12.39
Brutomarge75.46%
Nettowinstmarge21.97%
Schuld/Eigen Vermogen Verhouding3.5%

Hoe presteerde ADVENZYMES op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

1.1%

Huidig dividendrendement

41%

Uitbetalingsratio